Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

3.

Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group.

Altman RD, Moskowitz R.

J Rheumatol. 1998 Nov;25(11):2203-12. Erratum in: J Rheumatol 1999 May;26(5):1216.

PMID:
9818665
6.

Diacerein as adjuvant to diclofenac sodium in osteoarthritis knee.

Singh K, Sharma R, Rai J.

Int J Rheum Dis. 2012 Feb;15(1):69-77. doi: 10.1111/j.1756-185X.2011.01648.x. Epub 2011 Sep 6.

PMID:
22324949
7.

A double blind, randomized, placebo controlled study to evaluate the efficacy of erythromycin in patients with knee effusion due to osteoarthritis.

Sadreddini S, Noshad H, Molaeefard M, Moloudi R, Ardalan MR, Ghojazadeh M.

Int J Rheum Dis. 2009 Apr;12(1):44-51. doi: 10.1111/j.1756-185X.2009.01379.x.

PMID:
20374316
8.

A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis.

Kotevoglu N, Iyibozkurt PC, Hiz O, Toktas H, Kuran B.

Rheumatol Int. 2006 Feb;26(4):325-30. Epub 2005 Jun 15.

PMID:
15959784
9.

Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial.

Brown MT, Murphy FT, Radin DM, Davignon I, Smith MD, West CR.

J Pain. 2012 Aug;13(8):790-8. doi: 10.1016/j.jpain.2012.05.006. Epub 2012 Jul 10.

PMID:
22784777
10.

Greater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36.

Svensson O, Malmenäs M, Fajutrao L, Roos EM, Lohmander LS.

Ann Rheum Dis. 2006 Jun;65(6):781-4. Epub 2005 Nov 3.

12.

Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.

Schnitzer TJ, Ekman EF, Spierings EL, Greenberg HS, Smith MD, Brown MT, West CR, Verburg KM.

Ann Rheum Dis. 2015 Jun;74(6):1202-11. doi: 10.1136/annrheumdis-2013-204905. Epub 2014 Mar 13.

PMID:
24625625
13.

The long-term effects of non-steroidal anti-inflammatory drugs in osteoarthritis of the knee: a randomized placebo-controlled trial.

Scott DL, Berry H, Capell H, Coppock J, Daymond T, Doyle DV, Fernandes L, Hazleman B, Hunter J, Huskisson EC, Jawad A, Jubb R, Kennedy T, McGill P, Nichol F, Palit J, Webley M, Woolf A, Wotjulewski J.

Rheumatology (Oxford). 2000 Oct;39(10):1095-101.

PMID:
11035129
14.

Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.

Kivitz A, Eisen G, Zhao WW, Bevirt T, Recker DP.

J Fam Pract. 2002 Jun;51(6):530-7.

PMID:
12100776
17.
18.
19.

Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib.

Holt RJ, Fort JG, Grahn AY, Kent JD, Bello AE.

Phys Sportsmed. 2015 Jul;43(3):200-12. doi: 10.1080/00913847.2015.1074852. Epub 2015 Aug 3.

PMID:
26313454
20.

Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis.

Pincus T, Koch G, Lei H, Mangal B, Sokka T, Moskowitz R, Wolfe F, Gibofsky A, Simon L, Zlotnick S, Fort JG.

Ann Rheum Dis. 2004 Aug;63(8):931-9. Epub 2004 Apr 13.

Supplemental Content

Support Center